LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Health & Fitness
• Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, cancer, cells, patients, immunol, peptide, tumor, immunotherapy, human, vaccination, vaccine, melanoma, telomerase, response, cryptic, specific, immune, access, clin, privacy, cookies, content, immunological, vetsika, clinical, nat, regulatory, publish, research, search, responses, elenikyriaki, vassilis, georgoulias, mavroudis, antitumor, study, tcell, advanced, disease, activity, cell, cytotoxic, res, usa, immunother,

Topics {✒️}

month download article/chapter post-vaccination-induced immunological response eleni-kyriaki vetsika immune-related adverse events cd8 t-cell responses antitumor t-cell response post-chemotherapy maintenance immunotherapy low-dose interleukin-2 administered specific anti-tumor vaccine circulating tumor-reactive cd8+ van der bp small-cell lung cancer specific tumor-reactive ctl article cancer immunology specific immune response jeanne menez-jamet full article pdf synthetic peptide vaccine cryptic tumor epitopes human telomerase activity article vetsika related subjects privacy choices/manage cookies low-affinity hla-a2 tumor antigens recognized htert cryptic epitopes human tumour cells virus-specific cells cancer vaccine failure optimized variant tert572y check access instant access cell subpopulations determines low-affinity epitopes allogeneic tumor lysate human melanoma tissues european economic area defined genetic elements gross da magnetic resonance tracking fas-mediated suicide anti-ctla4 antibodies tumour infiltrating lymphocytes author information authors melanoma-reactive ctl human cancer cells shaping tumor immunogenicity immunological responses conditions privacy policy �iaso” general hospital

Questions {❓}

• Gabriel EM, Lattime EC (2007) Anti-CTL-associated antigen 4: are regulatory T cells a target?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
         description:Vx-001, an HLA-A*0201 restricted telomerase (TERT)-specific anti-tumor vaccine, is composed of the 9-mer cryptic TERT572 peptide and its optimized variant TERT572Y. We have previously shown that Vx-001 is non-toxic, highly immunogenic and in vaccinated NSCLC patients early specific immune response is associated with prolonged survival. The aim of the present study was to investigate the specific T-cell immune response against Vx-001. Fifty-five patients with chemo-resistant advanced solid tumors were vaccinated with TERT572Y (2 subcutaneous injections) followed by TERT572 peptide (4 subcutaneous injections) every 3 weeks. Specific immune response was evaluated by IFN-γ and perforin ELISpot and intracellular cytokine staining assays. TERT-reactive T cells were detected in 27 (51%) out of 53 evaluable patients after the 2nd vaccination and in 22 (69%) out of 32 evaluable patients after the completion of 6 vaccinations. Immune responses developed irrespective of the stage of disease and disease status before vaccination. Patients with disease progression at study entry who developed a post-vaccination-induced immunological response had a significant overall survival benefit compared to the post-vaccination non-responders. The Vx-001 vaccine is a promising candidate for cancer immunotherapy since it can induce a TERT-specific T-cell immune response that is associated with prolonged survival.
         datePublished:2011-08-20T00:00:00Z
         dateModified:2011-08-20T00:00:00Z
         pageStart:157
         pageEnd:168
         sameAs:https://doi.org/10.1007/s00262-011-1093-4
         keywords:
            Immunotherapy
            Vaccine
            CD8+ T cells
            Telomerase
            Cryptic peptide
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig5a_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig5b_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:61
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Eleni-Kyriaki Vetsika
               affiliation:
                     name:University of Crete, Voutes
                     address:
                        name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Georgios Konsolakis
               affiliation:
                     name:University of Crete, Voutes
                     address:
                        name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Despoina Aggouraki
               affiliation:
                     name:University of Crete, Voutes
                     address:
                        name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Athanasios Kotsakis
               affiliation:
                     name:University General Hospital of Heraklion
                     address:
                        name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elisavet Papadimitraki
               affiliation:
                     name:University General Hospital of Heraklion
                     address:
                        name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Soultana Christou
               affiliation:
                     name:University General Hospital of Heraklion
                     address:
                        name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeanne Menez-Jamet
               affiliation:
                     name:Vaxon Biotech
                     address:
                        name:Vaxon Biotech, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kostas Kosmatopoulos
               affiliation:
                     name:Vaxon Biotech
                     address:
                        name:Vaxon Biotech, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vassilis Georgoulias
               affiliation:
                     name:University of Crete, Voutes
                     address:
                        name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                        type:PostalAddress
                     type:Organization
                     name:University General Hospital of Heraklion
                     address:
                        name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                        type:PostalAddress
                     type:Organization
                     name:“IASO” General Hospital of Athens
                     address:
                        name:Department of Medical Oncology, “IASO” General Hospital of Athens, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dimitris Mavroudis
               affiliation:
                     name:University of Crete, Voutes
                     address:
                        name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                        type:PostalAddress
                     type:Organization
                     name:University General Hospital of Heraklion
                     address:
                        name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
      description:Vx-001, an HLA-A*0201 restricted telomerase (TERT)-specific anti-tumor vaccine, is composed of the 9-mer cryptic TERT572 peptide and its optimized variant TERT572Y. We have previously shown that Vx-001 is non-toxic, highly immunogenic and in vaccinated NSCLC patients early specific immune response is associated with prolonged survival. The aim of the present study was to investigate the specific T-cell immune response against Vx-001. Fifty-five patients with chemo-resistant advanced solid tumors were vaccinated with TERT572Y (2 subcutaneous injections) followed by TERT572 peptide (4 subcutaneous injections) every 3 weeks. Specific immune response was evaluated by IFN-γ and perforin ELISpot and intracellular cytokine staining assays. TERT-reactive T cells were detected in 27 (51%) out of 53 evaluable patients after the 2nd vaccination and in 22 (69%) out of 32 evaluable patients after the completion of 6 vaccinations. Immune responses developed irrespective of the stage of disease and disease status before vaccination. Patients with disease progression at study entry who developed a post-vaccination-induced immunological response had a significant overall survival benefit compared to the post-vaccination non-responders. The Vx-001 vaccine is a promising candidate for cancer immunotherapy since it can induce a TERT-specific T-cell immune response that is associated with prolonged survival.
      datePublished:2011-08-20T00:00:00Z
      dateModified:2011-08-20T00:00:00Z
      pageStart:157
      pageEnd:168
      sameAs:https://doi.org/10.1007/s00262-011-1093-4
      keywords:
         Immunotherapy
         Vaccine
         CD8+ T cells
         Telomerase
         Cryptic peptide
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig5a_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_Fig5b_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:61
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Eleni-Kyriaki Vetsika
            affiliation:
                  name:University of Crete, Voutes
                  address:
                     name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Georgios Konsolakis
            affiliation:
                  name:University of Crete, Voutes
                  address:
                     name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Despoina Aggouraki
            affiliation:
                  name:University of Crete, Voutes
                  address:
                     name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Athanasios Kotsakis
            affiliation:
                  name:University General Hospital of Heraklion
                  address:
                     name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elisavet Papadimitraki
            affiliation:
                  name:University General Hospital of Heraklion
                  address:
                     name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Soultana Christou
            affiliation:
                  name:University General Hospital of Heraklion
                  address:
                     name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeanne Menez-Jamet
            affiliation:
                  name:Vaxon Biotech
                  address:
                     name:Vaxon Biotech, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kostas Kosmatopoulos
            affiliation:
                  name:Vaxon Biotech
                  address:
                     name:Vaxon Biotech, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vassilis Georgoulias
            affiliation:
                  name:University of Crete, Voutes
                  address:
                     name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                     type:PostalAddress
                  type:Organization
                  name:University General Hospital of Heraklion
                  address:
                     name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                     type:PostalAddress
                  type:Organization
                  name:“IASO” General Hospital of Athens
                  address:
                     name:Department of Medical Oncology, “IASO” General Hospital of Athens, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dimitris Mavroudis
            affiliation:
                  name:University of Crete, Voutes
                  address:
                     name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
                     type:PostalAddress
                  type:Organization
                  name:University General Hospital of Heraklion
                  address:
                     name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:61
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Crete, Voutes
      address:
         name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
         type:PostalAddress
      name:University of Crete, Voutes
      address:
         name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
         type:PostalAddress
      name:University of Crete, Voutes
      address:
         name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
         type:PostalAddress
      name:University General Hospital of Heraklion
      address:
         name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
         type:PostalAddress
      name:University General Hospital of Heraklion
      address:
         name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
         type:PostalAddress
      name:University General Hospital of Heraklion
      address:
         name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
         type:PostalAddress
      name:Vaxon Biotech
      address:
         name:Vaxon Biotech, Paris, France
         type:PostalAddress
      name:Vaxon Biotech
      address:
         name:Vaxon Biotech, Paris, France
         type:PostalAddress
      name:University of Crete, Voutes
      address:
         name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
         type:PostalAddress
      name:University General Hospital of Heraklion
      address:
         name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
         type:PostalAddress
      name:“IASO” General Hospital of Athens
      address:
         name:Department of Medical Oncology, “IASO” General Hospital of Athens, Athens, Greece
         type:PostalAddress
      name:University of Crete, Voutes
      address:
         name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
         type:PostalAddress
      name:University General Hospital of Heraklion
      address:
         name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Eleni-Kyriaki Vetsika
      affiliation:
            name:University of Crete, Voutes
            address:
               name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Georgios Konsolakis
      affiliation:
            name:University of Crete, Voutes
            address:
               name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
               type:PostalAddress
            type:Organization
      name:Despoina Aggouraki
      affiliation:
            name:University of Crete, Voutes
            address:
               name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
               type:PostalAddress
            type:Organization
      name:Athanasios Kotsakis
      affiliation:
            name:University General Hospital of Heraklion
            address:
               name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
               type:PostalAddress
            type:Organization
      name:Elisavet Papadimitraki
      affiliation:
            name:University General Hospital of Heraklion
            address:
               name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
               type:PostalAddress
            type:Organization
      name:Soultana Christou
      affiliation:
            name:University General Hospital of Heraklion
            address:
               name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
               type:PostalAddress
            type:Organization
      name:Jeanne Menez-Jamet
      affiliation:
            name:Vaxon Biotech
            address:
               name:Vaxon Biotech, Paris, France
               type:PostalAddress
            type:Organization
      name:Kostas Kosmatopoulos
      affiliation:
            name:Vaxon Biotech
            address:
               name:Vaxon Biotech, Paris, France
               type:PostalAddress
            type:Organization
      name:Vassilis Georgoulias
      affiliation:
            name:University of Crete, Voutes
            address:
               name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
               type:PostalAddress
            type:Organization
            name:University General Hospital of Heraklion
            address:
               name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
               type:PostalAddress
            type:Organization
            name:“IASO” General Hospital of Athens
            address:
               name:Department of Medical Oncology, “IASO” General Hospital of Athens, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Dimitris Mavroudis
      affiliation:
            name:University of Crete, Voutes
            address:
               name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
               type:PostalAddress
            type:Organization
            name:University General Hospital of Heraklion
            address:
               name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
      name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
      name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
      name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
      name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
      name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
      name:Vaxon Biotech, Paris, France
      name:Vaxon Biotech, Paris, France
      name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
      name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
      name:Department of Medical Oncology, “IASO” General Hospital of Athens, Athens, Greece
      name:Laboratory of Tumor Biology, Medical School, University of Crete, Voutes, Heraklion, Greece
      name:Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(145)

• What's the financial gain of https://www.springernature.com/gp/authors?
• How much revenue does https://link.springernature.com/home/ bring in?
• How much does https://order.springer.com/public/cart rake in every month?
• How much does https://submission.nature.com/new-submission/262/3 earn?
• Profit of https://www.springernature.com/gp/librarians/licensing/agc/journals
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14555498 earns monthly
• Profit of http://scholar.google.com/scholar_lookup?&title=Natural%20T%20cell%20immunity%20against%20cancer&journal=Clin%20Cancer%20Res&volume=9&pages=4296-4303&publication_year=2003&author=Nagorsen%2CD&author=Scheibenbogen%2CC&author=Marincola%2CFM&author=Letsch%2CA&author=Keilholz%2CU
• How much does https://doi.org/10.1016%2FS0065-2776%2806%2990001-7 make?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16730260 have monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20immunosurveillance%20and%20immunoediting%3A%20the%20roles%20of%20immunity%20in%20suppressing%20tumor%20development%20and%20shaping%20tumor%20immunogenicity&journal=Adv%20Immunol&doi=10.1016%2FS0065-2776%2806%2990001-7&volume=90&pages=1-50&publication_year=2006&author=Smyth%2CMJ&author=Dunn%2CGP&author=Schreiber%2CRD earn?
• How profitable is https://doi.org/10.1034%2Fj.1600-065X.2002.18806.x?
• How much does http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20shared%20antigenic%20peptides%20recognized%20by%20human%20T%20cells&journal=Immunol%20Rev&doi=10.1034%2Fj.1600-065X.2002.18806.x&volume=188&pages=51-64&publication_year=2002&author=Bruggen%2CP&author=Zhang%2CY&author=Chaux%2CP generate monthly?
• Learn how profitable https://doi.org/10.1038%2Fnrg1656 is on a monthly basis
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16136653?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Telomeres%20and%20human%20disease%3A%20ageing%2C%20cancer%20and%20beyond&journal=Nat%20Rev%20Genet&doi=10.1038%2Fnrg1656&volume=6&pages=611-622&publication_year=2005&author=Blasco%2CMA
• Financial intake of https://doi.org/10.1126%2Fscience.7605428
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7605428?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Specific%20association%20of%20human%20telomerase%20activity%20with%20immortal%20cells%20and%20cancer&journal=Science&doi=10.1126%2Fscience.7605428&volume=266&pages=2011-2015&publication_year=1994&author=Kim%2CNW&author=Piatyszek%2CMA&author=Prowse%2CKR make?
• Find out how much https://doi.org/10.1038%2F22780 earns monthly
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10440377 is on a monthly basis
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Creation%20of%20human%20tumour%20cells%20with%20defined%20genetic%20elements&journal=Nature&doi=10.1038%2F22780&volume=400&pages=464-468&publication_year=1999&author=Hahn%2CWC&author=Counter%2CCM&author=Lundberg%2CAS&author=Beijersbergen%2CRL&author=Brooks%2CMW&author=Weinberg%2CRA
• https://doi.org/10.1038%2F13495's total income per month
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10502820
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20telomerase%20limits%20the%20growth%20of%20human%20cancer%20cells&journal=Nat%20Med&doi=10.1038%2F13495&volume=5&pages=1164-1170&publication_year=1999&author=Hahn%2CWC&author=Stewart%2CSA&author=Brooks%2CMW?
• What are the total earnings of https://doi.org/10.1016%2FS0952-7915%2896%2980078-1?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8902387?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Human%20tumor%20antigens%20recognized%20by%20T%20cells&journal=Curr%20Opin%20Immunol&doi=10.1016%2FS0952-7915%2896%2980078-1&volume=8&pages=628-636&publication_year=1996&author=Robbins%2CPF&author=Kawakami%2CY?
• How much revenue does https://doi.org/10.1111%2Fj.1600-065X.1995.tb00084.x generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Genes%20coding%20for%20tumor%20antigens%20recognized%20by%20cytolytic%20T%20lymphocytes&journal=Immunol%20Rev&doi=10.1111%2Fj.1600-065X.1995.tb00084.x&volume=145&pages=229-250&publication_year=1995&author=Van%2CPA&author=van%20der%2CBP&author=Coulie%2CPG earn?
• What's the profit of https://doi.org/10.1002%2F1521-4141%282000012%2930%3A12%3C3411%3A%3AAID-IMMU3411%3E3.0.CO%3B2-R?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11093159 net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20general%20strategy%20to%20enhance%20immunogenicity%20of%20low-affinity%20HLA-A2.%201-associated%20peptides%3A%20implication%20in%20the%20identification%20of%20cryptic%20tumor%20epitopes&journal=Eur%20J%20Immunol&doi=10.1002%2F1521-4141%282000012%2930%3A12%3C3411%3A%3AAID-IMMU3411%3E3.0.CO%3B2-R&volume=30&pages=3411-3421&publication_year=2000&author=Tourdot%2CS&author=Scardino%2CA&author=Saloustrou%2CE bring in each month?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14755339?
• How much does http://scholar.google.com/scholar_lookup?&title=High%20vaccination%20efficiency%20of%20low-affinity%20epitopes%20in%20antitumor%20immunotherapy&journal=J%20Clin%20Invest&volume=113&pages=425-433&publication_year=2004&author=Gross%2CDA&author=Graff-Dubois%2CS&author=Opolon%2CP make?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12023395
• How much income is http://scholar.google.com/scholar_lookup?&title=HER-2%2Fneu%20and%20hTERT%20cryptic%20epitopes%20as%20novel%20targets%20for%20broad%20spectrum%20tumor%20immunotherapy&journal=J%20Immunol&volume=168&pages=5900-5906&publication_year=2002&author=Scardino%2CA&author=Gross%2CDA&author=Alves%2CP earning monthly?
• What is the monthly revenue of https://doi.org/10.1073%2Fpnas.182418399?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12218171 makes per month
• How much does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20a%20human%20telomerase%20reverse%20transcriptase%20peptide%20of%20low%20affinity%20for%20HLA%20A2.1%20that%20induces%20cytotoxic%20T%20lymphocytes%20and%20mediates%20lysis%20of%20tumor%20cells&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.182418399&volume=99&pages=12275-12280&publication_year=2002&author=Hernandez%2CJ&author=Garcia-Pons%2CF&author=Lone%2CYC pull in?
• https://doi.org/10.1159%2F000096252's financial summary
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17047402 is on a monthly basis
• How much money does http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20the%20optimized%20cryptic%20peptide%20TERT%28572y%29%20in%20patients%20with%20advanced%20malignancies&journal=Oncology&doi=10.1159%2F000096252&volume=70&pages=306-314&publication_year=2006&author=Mavroudis%2CD&author=Bolonakis%2CI&author=Cornet%2CS generate?
• How much revenue does https://doi.org/10.1200%2FJCO.2006.10.3465 produce monthly?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17602077 have monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Vaccination%20of%20patients%20with%20advanced%20non-small-cell%20lung%20cancer%20with%20an%20optimized%20cryptic%20human%20telomerase%20reverse%20transcriptase%20peptide&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.10.3465&volume=25&pages=2727-2734&publication_year=2007&author=Bolonaki%2CI&author=Kotsakis%2CA&author=Papadimitraki%2CE
• How much profit is https://doi.org/10.1097%2FCJI.0b013e3180335b5e making per month?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17589294?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Induction%20of%20circulating%20tumor-reactive%20CD8%2B%20T%20cells%20after%20vaccination%20of%20melanoma%20patients%20with%20the%20gp100%20209%E2%80%932%C2%A0M%20peptide&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e3180335b5e&volume=30&pages=533-543&publication_year=2007&author=Meijer%2CSL&author=Dols%2CA&author=Jensen%2CSM
• See how much https://doi.org/10.1038%2Fnm0398-321 makes per month
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9500606?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Immunologic%20and%20therapeutic%20evaluation%20of%20a%20synthetic%20peptide%20vaccine%20for%20the%20treatment%20of%20patients%20with%20metastatic%20melanoma&journal=Nat%20Med&doi=10.1038%2Fnm0398-321&volume=4&pages=321-327&publication_year=1998&author=Rosenberg%2CSA&author=Yang%2CJC&author=Schwartzentruber%2CDJ?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8805655
• Earnings of http://scholar.google.com/scholar_lookup?&title=Improved%20induction%20of%20melanoma-reactive%20CTL%20with%20peptides%20from%20the%20melanoma%20antigen%20gp100%20modified%20at%20HLA-A%2A0201-binding%20residues&journal=J%20Immunol&volume=157&pages=2539-2548&publication_year=1996&author=Parkhurst%2CMR&author=Salgaller%2CML&author=Southwood%2CS
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9469433?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Enhanced%20generation%20of%20specific%20tumor-reactive%20CTL%20in%20vitro%20by%20selected%20Melan-A%2FMART-1%20immunodominant%20peptide%20analogues&journal=J%20Immunol&volume=160&pages=1750-1758&publication_year=1998&author=Valmori%2CD&author=Fonteneau%2CJF&author=Lizana%2CCM?
• How much revenue does https://doi.org/10.1097%2FCJI.0b013e318159f5ba generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18157017's total income per month
• How much money does http://scholar.google.com/scholar_lookup?&title=Analysis%20and%20characterization%20of%20antitumor%20T-cell%20response%20after%20administration%20of%20dendritic%20cells%20loaded%20with%20allogeneic%20tumor%20lysate%20to%20metastatic%20melanoma%20patients&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e318159f5ba&volume=31&pages=101-112&publication_year=2008&author=Bercovici%2CN&author=Haicheur%2CN&author=Massicard%2CS make?
• How much cash flow does https://doi.org/10.1016%2Fj.jim.2005.04.015 have monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16005014 gross monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Detection%20of%20human%20perforin%20by%20ELISpot%20and%20ELISA%3A%20ex%20vivo%20identification%20of%20virus-specific%20cells&journal=J%20Immunol%20Methods&doi=10.1016%2Fj.jim.2005.04.015&volume=302&pages=13-25&publication_year=2005&author=Zuber%2CB&author=Levitsky%2CV&author=Jonsson%2CG make?
• https://doi.org/10.1038%2Fnbt1154's total income per month
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16258544 generate?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Magnetic%20resonance%20tracking%20of%20dendritic%20cells%20in%20melanoma%20patients%20for%20monitoring%20of%20cellular%20therapy&journal=Nat%20Biotechnol&doi=10.1038%2Fnbt1154&volume=23&pages=1407-1413&publication_year=2005&author=Vries%2CIJM&author=Lesterhuis%2CWJ&author=Barentsz%2CJO?
• How much does https://doi.org/10.1200%2FJCO.2004.10.212 make?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15542798?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Immunologic%20and%20clinical%20outcomes%20of%20vaccination%20with%20a%20multiepitope%20melanoma%20peptide%20vaccine%20plus%20low-dose%20interleukin-2%20administered%20either%20concurrently%20or%20on%20a%20delayed%20schedule&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2004.10.212&volume=22&pages=4474-4485&publication_year=2004&author=Slingluff%2CCL&author=Petroni%2CGR&author=Yamshchikov%2CGV earns monthly
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10092779
• http://scholar.google.com/scholar_lookup?&title=Fas-mediated%20suicide%20of%20tumor-reactive%20T%20cells%20following%20activation%20by%20specific%20tumor%3A%20selective%20rescue%20by%20caspase%20inhibition&journal=J%20Immunol&volume=162&pages=3273-3279&publication_year=1999&author=Zaks%2CTZ&author=Chappell%2CDB&author=Rosenberg%2CSA&author=Restifo%2CNP's financial summary
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9218581 earning monthly?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Type%201%20versus%20type%202%20cytokine%20release%20by%20Vbeta%20T%20cell%20subpopulations%20determines%20in%20vivo%20antitumor%20reactivity%3A%20IL-10%20mediates%20a%20suppressive%20role&journal=J%20Immunol&volume=159&pages=664-673&publication_year=1997&author=Aruga%2CA&author=Aruga%2CE&author=Tanigawa%2CK&author=Bishop%2CDK&author=Sondak%2CVK&author=Chang%2CAE?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7553683?
• http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytokine%20mRNA%20in%20human%20melanoma%20tissues&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2FBF01521340&volume=41&pages=151-156&publication_year=1995&author=Lattime%2CEC&author=Mastrangelo%2CMJ&author=Bagasra%2CO&author=Li%2CW&author=Berd%2CD's total income per month
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12727833
• What's http://scholar.google.com/scholar_lookup?&title=Tumor-induced%20interleukin%2010%20suppresses%20the%20ability%20of%20splenic%20dendritic%20cells%20to%20stimulate%20CD4%20and%20CD8%20T-cell%20responses&journal=Cancer%20Res&volume=63&pages=2150-2157&publication_year=2003&author=Yang%2CAS&author=Lattime%2CEC's gross income?
• What's the profit of https://doi.org/10.1158%2F1078-0432.CCR-06-2820?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17289867?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Anti-CTL-associated%20antigen%204%3A%20are%20regulatory%20T%20cells%20a%20target%3F&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-2820&volume=13&pages=785-788&publication_year=2007&author=Gabriel%2CEM&author=Lattime%2CEC produce monthly?
• How much profit is https://doi.org/10.1073%2Fpnas.0830997100 making per month?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12682289 earns monthly
• http://scholar.google.com/scholar_lookup?&title=Biologic%20activity%20of%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20antibody%20blockade%20in%20previously%20vaccinated%20metastatic%20melanoma%20and%20ovarian%20carcinoma%20patients&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0830997100&volume=100&pages=4712-4717&publication_year=2003&author=Hodi%2CFS&author=Mihm%2CMC&author=Soiffer%2CRJ's financial summary
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15988909 generate?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Tumor%20immunotherapy%3A%20preclinical%20and%20clinical%20activity%20of%20anti-CTLA4%20antibodies&journal=Curr%20Opin%20Investig%20Drugs&volume=6&pages=582-591&publication_year=2005&author=Korman%2CA&author=Yellin%2CM&author=Keler%2CT
• Monthly income for https://doi.org/10.1084%2Fjem.182.2.459
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7543139
• Find out how much http://scholar.google.com/scholar_lookup?&title=CD28%20and%20CTLA-4%20have%20opposing%20effects%20on%20the%20response%20of%20T%20cells%20to%20stimulation&journal=J%20Exp%20Med&doi=10.1084%2Fjem.182.2.459&volume=182&pages=459-465&publication_year=1995&author=Krummel%2CMF&author=Allison%2CJP earns monthly
• https://doi.org/10.1073%2Fpnas.1533209100 income
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12826605?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Cancer%20regression%20and%20autoimmunity%20induced%20by%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20blockade%20in%20patients%20with%20metastatic%20melanoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1533209100&volume=100&pages=8372-8377&publication_year=2003&author=Phan%2CGQ&author=Yang%2CJC&author=Sherry%2CRM
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18503261 income
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Concurrent%20decrease%20in%20IL-10%20with%20development%20of%20immune-related%20adverse%20events%20in%20a%20patient%20treated%20with%20anti-CTLA-4%20therapy&journal=Cancer%20Immun&volume=8&publication_year=2008&author=Sun%2CJ&author=Schiffman%2CJ&author=Raghunath%2CA&author=Ng%2CTD&author=Chen%2CH&author=Sharma%2CP?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17388261
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Increased%20frequency%20of%20regulatory%20T%20cells%20in%20peripheral%20blood%20and%20tumour%20infiltrating%20lymphocytes%20in%20colorectal%20cancer%20patients&journal=Cancer%20Immun&volume=7&publication_year=2007&author=Ling%2CKL&author=Pratap%2CSE&author=Bates%2CGJ have monthly?
• What's the profit of https://doi.org/10.1158%2F1078-0432.CCR-06-1974?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17289891?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=A%20pilot%20study%20of%20CTLA-4%20blockade%20after%20cancer%20vaccine%20failure%20in%20patients%20with%20advanced%20malignancy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-1974&volume=13&pages=958-964&publication_year=2007&author=O%E2%80%99Mahony%2CD&author=Morris%2CJC&author=Quinn%2CC
• How much profit is https://doi.org/10.1016%2FS0092-8674%2800%2980856-9 making per month?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10850488
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Regulatory%20T%20cells%3A%20key%20controllers%20of%20immunologic%20self-tolerance&journal=Cell&doi=10.1016%2FS0092-8674%2800%2980856-9&volume=101&pages=455-458&publication_year=2000&author=Sakaguchi%2CS?
• Discover the revenue of https://doi.org/10.1038%2Fni1178
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15785760 income
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Naturally%20arising%20Foxp3-expressing%20CD25%2B%20CD4%2B%20regulatory%20T%20cells%20in%20immunological%20tolerance%20to%20self%20and%20non-self&journal=Nat%20Immunol&doi=10.1038%2Fni1178&volume=6&pages=345-352&publication_year=2005&author=Sakaguchi%2CS have monthly?
• How much does https://doi.org/10.1016%2Fj.semcancer.2005.11.005 rake in every month?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16376102
• How much profit is http://scholar.google.com/scholar_lookup?&title=Regulatory%20T%20cells%20in%20immune%20surveillance%20and%20treatment%20of%20cancer&journal=Semin%20Cancer%20Biol&doi=10.1016%2Fj.semcancer.2005.11.005&volume=16&pages=115-123&publication_year=2006&author=Yamaguchi%2CT&author=Sakaguchi%2CS making per month?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-011-1093-4?format=refman&flavour=references net monthly?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eleni-Kyriaki%20Vetsika?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eleni-Kyriaki%20Vetsika%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Georgios%20Konsolakis
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Georgios%20Konsolakis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Despoina%20Aggouraki produce monthly?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Despoina%20Aggouraki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Athanasios%20Kotsakis pull in?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Athanasios%20Kotsakis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elisavet%20Papadimitraki?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elisavet%20Papadimitraki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Soultana%20Christou income
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Soultana%20Christou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jeanne%20Menez-Jamet
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jeanne%20Menez-Jamet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kostas%20Kosmatopoulos generate?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kostas%20Kosmatopoulos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vassilis%20Georgoulias?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vassilis%20Georgoulias%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dimitris%20Mavroudis
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dimitris%20Mavroudis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• What's the total monthly financial gain of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-011-1093-4/MediaObjects/262_2011_1093_MOESM1_ESM.pdf?
• How profitable is https://s100.copyright.com/AppDispatchServlet?title=Immunological%20responses%20in%20cancer%20patients%20after%20vaccination%20with%20the%20therapeutic%20telomerase-specific%20vaccine%20Vx-001&author=Eleni-Kyriaki%20Vetsika%20et%20al&contentID=10.1007%2Fs00262-011-1093-4©right=Springer-Verlag&publication=0340-7004&publicationDate=2011-08-20&publisherName=SpringerNature&orderBeanReset=true?
• What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00262-011-1093-4?format=refman&flavour=citation?
• https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's revenue stream
• How much profit does https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research generate?
• What's https://www.springernature.com/gp/products's gross income?
• What's the monthly money flow for https://www.springernature.com/gp/librarians?
• Profit of https://www.springernature.com/gp/societies
• https://www.springernature.com/gp/partners's financial summary
• How much money does https://www.springer.com/ make?
• What's the income of https://www.nature.com/?
• How much profit does https://www.biomedcentral.com/ generate?
• How much does https://www.palgrave.com/ net monthly?
• Check the income stats for https://www.apress.com/
• How much money does https://www.springernature.com/gp/legal/ccpa generate?
• Learn about the earnings of https://www.springernature.com/gp/info/accessibility
• https://support.springernature.com/en/support/home's financial summary
• How much income is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earning monthly?
• What is the monthly revenue of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref